Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

Muhammad Zaeem Noman, Giacomo Desantis, Bassam Janji et al. · The Journal of Experimental Medicine · 2014 · 2.1K citations · Full text

Medicine, Immunology, Oncology +16

THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELAS

WILLIAM B. COLEY · The American Journal of the Medical Sciences · 1893 · 981 citations

Veterinary Medicine, Oncology, Pathology +5

Programmed death ligand-1 expression in non-small cell lung cancer

Vamsidhar Velcheti, Kurt A. Schalper, Daniel Carvajal et al. · Laboratory Investigation · 2013 · 753 citations · Full text

Medicine, Cancer Biology, Oncology +14

Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

Arianna Calcinotto, Paola Filipazzi, Matteo Grioni et al. · Cancer Research · 2012 · 623 citations

Life Sciences, Immunology, Oncology +17

Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy

Shari Pilon‐Thomas, Krithika N. Kodumudi, Asmaa El-Kenawi et al. · Cancer Research · 2016 · 592 citations · Full text

Life Sciences, Immunology, Oncology +17